- 全部删除
- 您的购物车当前为空
PHGDH-IN-3 是一种具有口服活性的磷酸甘油酸脱氢酶 (PHGDH) 抑制剂, 对 PHGDH 具有抑制作用,IC50 值为 2.8 μM。PHGDH-IN-3 可用于研究癌症。
为众多的药物研发团队赋能,
让新药发现更简单!
PHGDH-IN-3 是一种具有口服活性的磷酸甘油酸脱氢酶 (PHGDH) 抑制剂, 对 PHGDH 具有抑制作用,IC50 值为 2.8 μM。PHGDH-IN-3 可用于研究癌症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 993 | In stock | |
2 mg | ¥ 1,450 | In stock | |
5 mg | ¥ 2,380 | In stock | |
10 mg | ¥ 3,560 | In stock | |
25 mg | ¥ 5,720 | In stock | |
50 mg | ¥ 7,630 | In stock | |
100 mg | ¥ 9,870 | In stock | |
500 mg | ¥ 19,800 | In stock |
PHGDH-IN-3 相关产品
产品描述 | PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 2.8 μM against PHGDH. PHGDH-IN-3 can be used in studies about cancer. |
靶点活性 | PHGDH:2.33 μM, PHGDH:2.8 μM |
体外活性 | PHGDH-IN-3具有良好的酶抑制活性,其IC50值为2.8 μM。[1] 该化合物与PHGDH蛋白具有高结合亲和力,Kd值为2.33 μM。[1] 对于PHGDH基因扩增或过表达的细胞系,PHGDH-IN-3表现出敏感性。[1] 此外,PHGDH-IN-3能够限制在MDA-MB-468细胞中从葡萄糖到丝氨酸的新生合成。[1] |
体内活性 | PHGDH-IN-3(1, 3 mg/kg;口服、静脉注射;)展现了优秀的体内药代动力学特性。[1] PHGDH-IN-3(12.5, 25, 50 mg/kg;腹腔注射;每天一次,连续31天)在PC9异种移植小鼠模型中显示出显著的抗肿瘤效果。[1] |
分子量 | 495.55 |
分子式 | C24H18FN3O4S2 |
CAS No. | 2893778-31-7 |
Smiles | N(C(=O)C1=CC=C(S(NC2=CC(C(C)=O)=CC=C2)(=O)=O)C=C1)C3=NC(=CS3)C4=CC(F)=CC=C4 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 90.0 mg/mL (181.6 mM), Sonication and heating to 70℃ are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容